topotecan has been researched along with Oligodendroglioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bélanger, K; Bergeron, J; Burdette-Radoux, S; Cairncross, G; Eisenhauer, E; Forsyth, P; Gertler, S; Ludwin, S; MacDonald, D; Soulières, D; Wainman, N | 1 |
1 trial(s) available for topotecan and Oligodendroglioma
| Article | Year |
|---|---|
A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma.
Topics: Astrocytoma; Fatigue; Humans; Infusions, Intravenous; Oligodendroglioma; Topotecan | 2003 |